Armata Pharmaceuticals, Inc. Common Stock (ARMP)
R&D to Revenue
302.23%
Quarterly · Period ending:
ARMP R&D to Revenue
Latest reported302.23%period ending
Latest reported302.23%period ending
ARMP Quarterly R&D/Revenue (0.00% → 302.23%)
Latest values, visible window
High-resolution chart · PNG
ARMP r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 1,066.6667% | |
| 3,500% | |
| 387.5% | |
| 1,100% | |
| 775% | |
| 206.6667% | |
| 450% | |
| 2,400% | |
| 1,200% | |
| 0% | |
| 1,900% | |
| 2,000% | |
| 2,000% | |
| 1,800% | |
| 950% | |
| 1,700% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |